Linde plc Ordinary Shares
NASDAQ: LIN · BASIC MATERIALS · SPECIALTY CHEMICALS
Updated 2026-04-29
Linde plc Ordinary Shares (LIN) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
Linde management has not issued specific multi-year revenue targets in the available data. Q4 2025 earnings showed 5.8% YoY revenue growth to $8.76B quarterly. Management is guiding FY2026 adjusted EPS in line with analyst estimates, with focus on organic growth, capital deployment in hydrogen/clean energy, and strategic facility expansions (North Carolina ASU by end-2028, Wisconsin facility also announced).
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.9B | $33.0B | $34.0B | $35.9B | $37.7B | $39.7B | $41.8B | $44.1B |
| Revenue growth | — | 0.5% | 3.0% | 5.7% | 5.0% | 5.2% | 5.4% | 5.6% |
| EPS | $14.21 | $15.51 | $16.45 | $18.01 | $19.68 | $21.50 | $23.65 | $26.00 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $954.94 | $1,005.20 | $1,055.46 | $1,105.72 | $1,155.98 |
Catalysts & risks
Methodology
Linde plc Ordinary Shares's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 29 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.